0 Acta Scientific | International Open Library | Open Access Journals Publishing Group

Acta Scientific Women's Health (ASWH)(ISSN: 2582-3205)

Mini Review Volume 4 Issue 3

Cervix Cancer Management and Challenges in Coming Years. How to Deal After FIGO 2018 Staging Update, SENTICOL I-II and LACC Studies Results?

MA Jellouli* and J Mathis

Department of Gynecology and Obstetrics, Bienne Hospital, Switzerland

*Corresponding Author: MA Jellouli, Department of Gynecology and Obstetrics, Bienne Hospital, Switzerland.

Received: January 20, 2022; Published: February 25, 2022

Abstract

  As the 4th most common cancer and the 4th cause of cancer death in women in the world, Cervix cancer still occupy an important part of oncological centers activity and has benefited from several changes in its Management over the past 4 years.

References

  1. Miriam Y Salib., et al. “2018 FIGO Staging Classification for Cervical Cancer: Added Benefits of Imaging”. Radiographics6 (2020): 1807-1822.
  2. Gloria Salvo., et al. “Revised 2018 International Federation of Gynecology and Obstetrics (FIGO) cervical cancer staging: A review of gaps and questions that remain”. The International Journal of Gynecological Cancer6 (2020): 873-878.
  3. Amelie de Gregorioa., et al. “Influence of the New FIGO Classification for Cervical Cancer on Patient Survival: A Retrospective Analysis of 265 Histologically Confirmed Cases with FIGO Stages IA to IIB”. Oncology 98 (2020): 91-97.
  4. Ding-Ding Yan., et al. “Prognostic value of the 2018 FIGO staging system for cervical cancer patients with surgical risk factors”. Cancer Management and Research 11 (2019): 5473-5480.
  5. Ramirez PT., et al. “Minimally invasive versus abdominal radical hysterectomy for cervical cancer”. The New England Journal of Medicine 379 (2018): 1895-1904.
  6. ESMO Guidelines Committee. eUpdate-Cervical Cancer Treatment Recommendations: Management of Local/Locoregional Disease; Primary Treatment (Clinical Practice Guidelines); European Society for Medical Oncology: Lugano, Switzerland (2020).
  7. NCCN Guidelines Version. Cervical Cancer (2019).
  8. Kohler C., et al. “Laparoscopic radical hysterectomy with transvaginal closure of vaginal cuff - a multicenter analysis”. The International Journal of Gynecological Cancer 29 (2019): 845-850.
  9. Kanao H., et al. “Feasibility and outcome of total laparoscopic radical hysterectomy with no-look no-touch technique for FIGO IB1 cervical cancer”. Journal of Gynecologic Oncology3 (2019): 71.
  10. Greggi S., et al. “Surgical management of early cervical cancer: When is laparoscopic appropriate?” Current Oncology Reports 22 (2020): 7.
  11. Zhang SS., et al. “Efficacy of robotic radical hysterectomy for cervical cancer compared with that of open and laparoscopic surgery: A separate meta-analysis of high-quality studies”. Medicine 98 (2019): e14171.
  12. Fabrice Lécuru., et al. “Bilateral negative sentinel nodes accurately predict absence of lymph node metastasis in early cervical cancer: results of the SENTICOL study”. Journal of Clinical Oncology13 (2011): 1686-1691.
  13. Eiriksson L and Covens A. “Sentinel lymph node mapping in cervical cancer: the future?” BJOG: An International Journal of Obstetrics and Gynaecology 119 (2012): 129-133.
  14. Roy M., et al. “Value of sentinel node mapping in cancer of the cervix”. Gynecologic Oncology Volume2 (2011): 269-274.
  15. Beatrice Cormier., et al. “Establishing a sentinel lymph node mapping algorithm for the treatment of early cervical cancer”. Gynecologic Oncology2 (2011): 275-280.
  16. Achouri A., et al. “Complications of lymphadenectomy for gynecologic cancer”. European Journal of Surgical Oncology (EJSO)1 (2013): 81-86.
  17. Mathevet P., et al. “Sentinel lymph node biopsy for early cervical cancer: Results of a randomized prospective, multicenter study (Senticol 2) comparing adding pelvic lymph node dissection vs sentinel node biopsy only”. Gynecologic Oncology 145 (2017): 2-3.

Citation

Citation: MA Jellouli and J Mathis. “Cervix Cancer Management and Challenges in Coming Years. How to Deal After FIGO 2018 Staging Update, SENTICOL I-II and LACC Studies Results?". Acta Scientific Women's Health 4.3 (2022): 39-42.

Copyright

Copyright: © 2022 MA Jellouli and J Mathis. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days

Indexed In





News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 30, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US